Hepatocellular Carcinoma
Conditions
Sponsors
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) With reference to the 2018 edition of the systems of primary liver cancer diagnosis and treatment guidelines and the 2018 edition of the diagnosis and treatment of hepatocellular carcinoma (HCC) merger portal venous tumor emboli multidisciplinary China expert consensus, the eighth edition of the AJCC TNM staging system standards and PVTT program classification, selection of stage Ia, Ib merge each type of portal venous tumor emboli and II - stage IIIb (and/or merge each type of portal venous tumor emboli) of postoperative patients with liver cancer; (2) Estimated survival >=3 months; (3) Physical condition (ECOG) score <=2; (4) Aged 18 to 80 years old; (5) Patients voluntarily participate in the study of this project and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with a history of other malignant tumors; (2) having a serious or uncontrolled medical condition or an infected person; (3) Participating in other clinical studies or participating in other clinical studies within 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| AFP;OS; | — |
Countries
China
Contacts
Public ContactWang Yindong
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed